These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34189870)

  • 21. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
    Mtisi TF; Frishman WH
    Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.
    Paolillo S; Mapelli M; Bonomi A; Corrà U; Piepoli M; Veglia F; Salvioni E; Gentile P; Lagioia R; Metra M; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Carubelli V; Scrutino D; Badagliacca R; Raimondo R; Emdin M; Magrì D; Correale M; Parati G; Caravita S; Spadafora E; Re F; Cicoira M; Frigerio M; Bussotti M; Minà C; Oliva F; Battaia E; Belardinelli R; Mezzani A; Pastormerlo L; Di Lenarda A; Passino C; Sciomer S; Iorio A; Zambon E; Guazzi M; Pacileo G; Ricci R; Contini M; Apostolo A; Palermo P; Clemenza F; Marchese G; Binno S; Lombardi C; Passantino A; Perrone Filardi P; Agostoni P
    Eur J Heart Fail; 2017 Jul; 19(7):904-914. PubMed ID: 28233458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
    Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
    Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.
    Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK
    Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different Impact of Beta-Blockers on Long-Term Mortality in Heart Failure Patients with and without Chronic Obstructive Pulmonary Disease.
    Higuchi S; Kohno T; Kohsaka S; Shiraishi Y; Takei M; Goda A; Shoji S; Nagatomo Y; Yoshikawa T
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic obstructive airway disease among patients hospitalized with acute heart failure; clinical characteristics, precipitating factors, management and outcome: Observational report from the Middle East.
    Khafaji HA; Sulaiman K; Singh R; Alhabib KF; Asaad N; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; Almahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; Faleh HA; Elasfar A; Panduranga P; Suwaidi JA
    Acute Card Care; 2015 Dec; 17(4):55-66. PubMed ID: 27712142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular function and prognosis of patients with heart failure coexistent with chronic obstructive pulmonary disease.
    Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Abe S; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    J Cardiol; 2014 Oct; 64(4):256-64. PubMed ID: 24674751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial Strain for Identification of β-Blocker Responders in Heart Failure with Preserved Ejection Fraction.
    Park JJ; Choi HM; Hwang IC; Park JB; Park JH; Cho GY
    J Am Soc Echocardiogr; 2019 Nov; 32(11):1462-1469.e8. PubMed ID: 31540679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
    Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
    JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation.
    Galves R; Da Costa A; Pierrard R; Bayard G; Guichard JB; Isaaz K
    Echocardiography; 2020 Sep; 37(9):1392-1398. PubMed ID: 32815195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
    Richardson A; Tolley E; Hartmann J; Reedus J; Bowlin B; Finch C; Sands CW; Self T
    Respir Med; 2016 Oct; 119():135-140. PubMed ID: 27692135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.
    Kwon BJ; Kim DB; Jang SW; Yoo KD; Moon KW; Shim BJ; Ahn SH; Cho EJ; Rho TH; Kim JH
    Eur J Heart Fail; 2010 Dec; 12(12):1339-44. PubMed ID: 20861127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute heart failure with accompanying chronic obstructive pulmonary disease: should we focus on beta blockers?
    Ege MR; Guray U; Guray Y; Yilmaz MB; Yucel O; Zorlu A; Tandogan I
    Herz; 2012 Nov; 37(7):796-800. PubMed ID: 22699995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial strain to identify benefit from beta-blockers in patients with heart failure with reduced ejection fraction.
    Park CS; Park JJ; Hwang IC; Park JB; Park JH; Cho GY
    ESC Heart Fail; 2022 Apr; 9(2):1248-1257. PubMed ID: 35001562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
    Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
    Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
    Staszewsky L; Wong M; Masson S; Barlera S; Carretta E; Maggioni AP; Anand IS; Cohn JN; Tognoni G; Latini R;
    J Card Fail; 2007 Dec; 13(10):797-804. PubMed ID: 18068611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications.
    Mascarenhas J; Lourenço P; Lopes R; Azevedo A; Bettencourt P
    Am Heart J; 2008 Mar; 155(3):521-5. PubMed ID: 18294490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.